Last month, direct-to-consumer (DTC) genetic testing company 23andMe announced that it would begin providing customers with health information again after retooling its offerings to meet FDA regulations. The reintroduction of 23andMe to the consumer marketplace is a huge milestone for the genetic testing industry, which has evolved from blood tests …
© 2025 Hedgeye Risk Management, LLC
Substack is the home for great culture